SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 13F-NT - Quarterly report filed by institutional managers, Notice:
SEC Accession No. 0001104659-20-022062
Filing Date
2020-02-14
Accepted
2020-02-14 17:25:44
Documents
1
Period of Report
2019-12-31
Effectiveness Date
2020-02-14

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 13F-NT  
1 primary_doc.xml 13F-NT 2220
  Complete submission text file 0001104659-20-022062.txt   3355
Mailing Address 9TH FLOOR, BUILDING A NO. 1289 YISHAN ROAD SHANGHAI F4 200233
Business Address 9TH FLOOR, BUILDING A NO. 1289 YISHAN ROAD SHANGHAI F4 200233 86 21 23138051
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Filer) CIK: 0001615258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 1231
Type: 13F-NT | Act: 34 | File No.: 028-18303 | Film No.: 20622068